CDK1 and skin squamous cell carcinoma: Here, we found that KY19382 and KY19334 inhibited the manifestation of malignant phenotype by inhibiting the Wnt/β-catenin signaling of human cutaneous squamous cell carcinoma (cSCC) cells, which was associated with suppression of cyclin-dependent kinase 1 (CDK1) expression.